Ethical Limits On Intracellular Catalytic Activity.

Ethical Limits on Intracellular Catalytic Activity

1. introduction

Intracellular catalytic activity refers to chemical reactions inside human cells that are accelerated by biological substances called enzymes. These enzymes help cells produce energy, repair damage, break down harmful substances, and maintain normal biological functions.

Modern biotechnology can influence these activities through medicines, genetic engineering, and enzyme-based treatments. Such methods may help treat diseases and improve cellular functions. However, uncontrolled changes in enzyme activity may damage healthy cells and disturb normal body processes.

Therefore, controlling intracellular catalytic activity must follow ethical principles, medical safety standards, and legal safeguards.

2. meaning and purpose

Catalytic activity occurs when enzymes speed up chemical reactions without being consumed in the process.

Inside cells, enzymes perform important functions, including:

Producing energy for cellular activities.

Helping repair damaged DNA.

Breaking down harmful substances.

Supporting protein production.

Controlling metabolic reactions.

Maintaining normal cell growth.

Scientists may modify these activities to correct enzyme deficiencies, treat metabolic disorders, or develop new medical therapies.

However, changing one enzyme may affect several other cellular processes. Therefore, such modifications require careful scientific examination.

3. ethical principles

a. informed consent: Patients must understand the purpose, benefits, risks, and possible side effects of enzyme-based treatments.

b. patient safety: Researchers must ensure that changes in catalytic activity do not cause unnecessary cellular damage.

c. scientific responsibility: Experimental treatments must be supported by reliable scientific evidence.

d. human dignity: Genetic and cellular modifications must respect human dignity and bodily autonomy.

e. privacy: Personal genetic, medical, and cellular information must remain confidential.

4. legal framework in India

Article 21 of the Indian Constitution protects life and personal liberty. It supports bodily autonomy, dignity, and informed medical decision-making.

The ICMR National Ethical Guidelines, 2017, establish ethical standards for biomedical research involving human participants and biological materials.

The Drugs and Cosmetics Act, 1940, and applicable rules regulate medicines and relevant biological products. Experimental enzyme-based treatments must follow applicable clinical research and safety requirements.

These legal protections help prevent unsafe medical practices and protect individuals participating in biotechnology research.

5. relevant case laws

a. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

In this case, a doctor performed an additional surgical procedure without obtaining proper consent from the patient. The Supreme Court held that medical treatment requires valid and informed consent.

This principle applies to intracellular catalytic treatments because patients must understand the possible effects of changing enzyme activity before accepting treatment.

b. Jacob Mathew v. State of Punjab (2005) 6 SCC 1

The Supreme Court explained that doctors must exercise reasonable skill and care while treating patients. Failure to follow the accepted standard of medical care may result in liability for negligence.

This case is relevant because enzyme-based therapies require scientific knowledge, proper supervision, and careful monitoring.

c. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21. It protected personal information and individual autonomy.

This principle applies because cellular and genetic research may involve sensitive biological information that must be protected against unauthorised use.

d. Common Cause v. Union of India (2018) 5 SCC 1

The Supreme Court recognised personal autonomy and the importance of individual decisions concerning medical treatment.

This principle is relevant because patients should have the freedom to accept or refuse enzyme-modifying treatments after receiving proper information.

These judgments establish general principles of medical consent, safety, privacy, and autonomy. They do not directly decide every issue involving intracellular catalytic activity.

6. major ethical challenges

Cellular damage: Uncontrolled enzyme activity may damage healthy cells.

Genetic risks: Some modifications may produce unexpected biological effects.

Unknown consequences: Long-term effects of new treatments may not be fully understood.

Commercial exploitation: Companies may promote unproven enzyme therapies through misleading claims.

Unequal access: Expensive biotechnology treatments may not be available to everyone.

Privacy violations: Genetic information may be misused by unauthorised organisations.

7. preventive measures

Obtain informed consent before treatment.

Conduct proper scientific testing.

Use qualified medical professionals.

Obtain ethical approval for human research.

Monitor patients for unexpected cellular effects.

Protect genetic and medical information.

Prevent misleading advertisements about experimental treatments.

8. conclusion

Intracellular catalytic activity is essential for normal cellular functions and human health. Modern biotechnology may help regulate these processes to treat serious diseases. However, uncontrolled modification can create significant biological risks. Therefore, all treatments must follow scientific evidence, informed consent, and proper medical supervision. Human dignity, patient safety, and fundamental rights must remain the main priorities.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT